Jayakumar Jerobin
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
-
- Extracellular vesicles in disease
- RNA Interference and Gene Delivery
- Circular RNAs in diseases
Papers in ⓘ
-
- Metabolism, Diabetes, and Cancer 2
-
- Adipose Tissue and Metabolism 3
- Nutrition and Health in Aging 3
- Co-authors
- Abdul‐Badi Abou‐Samra (17 shared papers)Hana Q. Sadida (3 shared papers)Ajaz A. Bhat (2 shared papers)Rashid Mir (1 shared paper)Muzafar A. Macha (2 shared papers)Rakesh Kumar (1 shared paper)Ammira S. Al-Shabeeb Akil (2 shared papers)Naseh A. Algehainy (1 shared paper)
- Journals
- Frontiers in Endocrinology (6 papers)Obesity Reviews (1 paper)Lipids in Health and Disease (1 paper)Reviews in Cardiovascular Medicine (1 paper)Clinical Transplantation (1 paper)
- Partner nations
- QatarUnited KingdomBahrain
In The Last Decade
Jayakumar Jerobin
23 papers receiving 811 citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 218
- Molecular Biology 530
- Rheumatology 101
- Immunology 109
- Physiology 108
Countries citing papers authored by Jayakumar Jerobin
This map shows the geographic impact of Jayakumar Jerobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayakumar Jerobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayakumar Jerobin more than expected).
Fields of papers citing papers by Jayakumar Jerobin
This network shows the impact of papers produced by Jayakumar Jerobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayakumar Jerobin. The network helps show where Jayakumar Jerobin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jayakumar Jerobin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Extracellular vesicles as tools and targets in therapy for diseases Hit paper breakdown → | 2024 | 546 |
| 2 | 2019 | 78 | |
| 3 | 2019 | 36 | |
| 4 | 2019 | 28 | |
| 5 | 2012 | 19 | |
| 6 | 2020 | 16 | |
| 7 | 2021 | 11 | |
| 8 | 2021 | 10 | |
| 9 | 2024 | 9 | |
| 10 | 2022 | 8 | |
| 11 | 2015 | 8 | |
| 12 | 2012 | 8 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 7 | |
| 15 | 2022 | 6 | |
| 16 | 2021 | 5 | |
| 17 | 2024 | 5 | |
| 18 | 2019 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2020 | 2 |
About Jayakumar Jerobin
Jayakumar Jerobin is a scholar working on Molecular Biology, Physiology, Rheumatology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 820 indexed citations. Recurring topics across this work include GDF15 and Related Biomarkers (5 papers), Apelin-related biomedical research (3 papers), Adipose Tissue and Metabolism (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Nutrition and Health in Aging (3 papers), MicroRNA in disease regulation (2 papers), Cystic Fibrosis Research Advances (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Cancer Research (218 citations), Molecular Biology (530 citations), Rheumatology (101 citations), Immunology (109 citations) and Physiology (108 citations). Jayakumar Jerobin has collaborated with scholars based in Qatar, United Kingdom and Bahrain. Frequent co-authors include Abdul‐Badi Abou‐Samra, Hana Q. Sadida, Ajaz A. Bhat, Rashid Mir, Muzafar A. Macha, Rakesh Kumar, Ammira S. Al-Shabeeb Akil, Naseh A. Algehainy, Faisal H. Altemani and Mohammad Alanazi. Their work appears in journals such as Frontiers in Endocrinology, Obesity Reviews, Lipids in Health and Disease, Reviews in Cardiovascular Medicine and Clinical Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.